Building Better Strategies for the Management of Chronic Lymphocytic Leukemia: Clinical Controversies and Opportunities to Improve Outcomes

AUDIO/VIDEO PRESENTATIONS Participants must view each section in its entirety to receive full credit for this program.
	Newly Diagnosed CLL: Timing and Regimen Selection
	Management of Relapsed/Refractory CLL: Clinical Challenges and Opportunities
	The Future of CLL Therapy: Prognostic Factors…Agents…Combinations
	Panel Discussion/Question and Answer Session
	Entire Symposium

CLAIM CREDIT
	Click Here for Post Test

This activity is sponsored by

This activity is supported by an educational grant from

QUESTIONS

Ryann Taylor
rtaylor@educationalconcepts.net
1.770.933.2053
Educational Concepts Group, LLC
1300 Parkwood Circle SE | Suite 325
Atlanta, GA 30339

FACULTY

Susan O’Brien, MD – Chair
Professor of Medicine
Department of Leukemia
The University of Texas
MD Anderson Cancer Center
Houston, Texas

John G. Gribben, MD,
DSc, FMedSci
Professor of Experimental Cancer Medicine
Institute of Cancer
Barts and the London School of Medicine
London, United Kingdom

Anders Österborg, MD, PhD
Professor of Oncology
Karolinska University Hospital and Institute
Stockholm, Sweden

Content on this page requires a newer version of Adobe Flash Player.